Papovaviruses have been isolated from many animals including man (2, 6, 9, 12) . The papova group of deoxyribonucleic acid (DNA) viruses is known for its potential to transform cells in vitro and cause tumors in vivo (5, 11, 21) . Although picodna viruses have been reported from piglet and swine breeding herds (4, 10) , there are no reports in the literature of a swine papovavirus (SPV) having been isolated in vitro or seen in tissues by electron microscopy. Parrish (13, 14) reported a transmissable genital papilloma in swine, but the agent was not propagated in vitro. Recently, the agent causing this disease has been classified as a member of the poxviruses by Allison (1) and Andrewes and Pereira (2) . During a preliminary study in which we were searching for adventitious agents in swine pancreas-derived trypsin, a virus was isolated whose biological and physical characteristics are the subject of this communication. We are still uncertain as to the exact source of this isolate, but experimental evidence is presented which suggests that the isolate is a swine agent and a new member of the papovavirus group.
MATERIALS AND METHODS
Cell cultures. The virus was propagated in two pig kidney cell lines derived from different clones of a parent line, PK-2a, established by Stice (15) . One clone has been referred to as the PK-15 cell line (15) and the second clone as the PS cell line (7) . The PK-15 cell line was purchased from Flow Laboratories, Inc supplemented with virus-screened 10c% fetal calf serum (FCS; Industrial Biological Laboratories, Rockville, Md.) and neomycin (20ug/mrnl). Confluent monolayers were maintained in BME with 1 %c FCS.
Viral assay: immunofluorescence. The technique we used in the immunofluorescence focus assay has been described previously (20) .
Antibody against SPV was prepared artificially by inoculating 0.2 ml of cesium chloride-purified virus and Freund's complete adjuvant (1:1) into young adult guinea pigs. The inoculation sites (0.05 ml/site) were the rear foot pads and the upper flanks. After 1 month, the guinea pigs received booster shots at the same sites; 10 Virus purification, concentration, and buoyant density determinations. Infected PK-15 cells were disrupted by a single freeze-thawing at -50 C, followed by sonic oscillation for 3 min at 38 ma with a Branson sonifier cell disruptor, model no. W140D. After removing large particulate matter by low-speed centrifugation, the virus suspension was placed on a preformed gradient and centrifuged for 3 hr at 100,000 X g in a Beckman model L-265 ultracentrifuge. A modified procedure for purification was also employed. Nonidet P-40, a nonionic detergent, was mixed with frozen-thawed crude virus to a final concentration of 0.1 %. This mixture was treated by sonic oscillation for 6 min and was clarified by filtration through Celite no. 512 (Johns-Manville). Then the material was centrifuged on a preformed gradient at 100,000 X g for 14 to 17 hr. Fractions were collected through a puncture in the tube bottoms, and each fraction was examined for virus particles by electron microscopy. Buoyant density measurement were made on virus-containing fractions with a densitometer. The densitometer was calibrated by plotting refractiveindex readings against densities of cesium chloride solutions determined by weight-volume measurements.
Electron microscopy. The technique for particle counting was a modification of the Sharp method (17) for negative staining as described by Smith and Melnick (19) .
Neutralization tests. Neutralization tests were carried out by employing an immunofluorescence focus assay method described previously (18) . A reduction of 80% or greater in infectious virus titer was considered the serum neutralization end point.
Ether sensitivity determination. We used a standard procedure described by Kapikian (8) for determining ether sensitivity of viruses. This consisted of treating virus suspensions with equal volumes of ether at 4 C for 18 to 24 hr. Herpes simplex virus was used in the test system as a positive control, and assay of this virus was performed as described by Roizman and Roane (16) . Treated and untreated SPV was titrated in PS cells, and infectivity was measured by the immunofluorescence focus assay.
Nucleic acid determination. PS cells were adsorbed with 0.2 ml of undiluted virus suspension for 1 hr at room temperature and then maintained on BME maintenance media containing 0.1 mg of 5-iodo-2'-deoxyuridine (IUDR) per ml. After 4 days the cell monolayers were scraped and frozen at -50 C. Thawed samples of IUDR-treated and untreated control cells were then titrated in PS cells. Adenovirus type 2 propagated in HA cells was used as a known DNA virus control and reovirus type 3 propagated in PS cells served as a known ribonucleic acid (RNA) virus control. All virus titers were determined by measuring infectivity with the immunofluorescence focus assay. RFSULTS Source of virus. SPV was initially isolated by us during a search for adventitious viruses in swinederived pancreatic trypsin. In this study we exposed PK-15 cells to concentrated trypsin whose activity was inhibited by mixing with FCS. After removing the trypsin, the cells were maintained on BME with 1 % FCS. Some treated PK-1 5 cell cultures slowly developed cytopathic effects (CPE), which we believed to be virus-induced because electron microscopic examination of frozen and thawed material from these cultures revealed numerous cubically symmetrical particles.
Observation of virus-infected cell cultures. Infected PK-15 cells maintained in BME medium with 10%, FCS (normal cell growth medium) could be propagated and held for prolonged periods of time without obvious CPE. If infected cell monolayers were held in BME maintenance media (1% FCS) with weekly medium changes, cell monolayers slowly degenerated within a period of 3 weeks. Virus titers of supernatant fluids from these cultures averaged about 104 infectious doses per ml when titrated in PS cells. Particle counting of the same material resulted in counts of 1010 virus particles/ml. Therefore, the calculated particle-infectivity ratio approximated 106 particles per infectious dose.
There was no observable CPE in primary pig embryonic kidney cells. Electron microscopy. The SPV particle, when A negatively stained, exhibited cubic symmetry and did not appear to possess an envelope (Fig. iB) . In many instances, however, membrane-like material was found associated with single particles, as well as with clusters of particles (Fig.  IC) (Fig. 2) . Filamentous forms were observed which measured 35.8 nm in diameter (Fig. 1A) .
Buoyant density. Sonically treated crude virus, clarified by low-speed centrifugation, banded with a peak infectivity at a density of 1.22 g/ml, as can be seen in Fig. 3 . Electron microscopic examination of these fractions showed membrane-like material associated with virus particles similar to that seen in Fig. 1C . Ether treatment of banded virus, when rebanded, did not show a significant change in density. When the crude virus was prepared for purification and concentration by a modified procedure employing Celite filtration and addition of Nonidet P-40, the infectivity peak was at a density of 1.35 g/ml. Electronmicroscopic examination of these fractions showed virus particles free of membrane-like material. In most instances the neutralization titers were greater than we were able to obtain artifically in guinea pigs.
We conclude that this agent is SPV on the basis of (i) its physical characteristics, (ii) its nucleic acid type, (iii) the absence of essential lipids, (iv) its replication being restricted to swine cells, and (v) the presence of naturally occurring antibody in swine.
At this time, studies are being conducted to determine the original source of the SPV we isolated. We are considering the possibilities (i) that the agent is indigenous in the PK-15 cell line we obtained for these studies and (ii) that the agent is present in some lots of pancreas-derived trypsin to which our PK-15 cells were exposed. If the latter is correct, high-passage levels of stable swine cells (such as the PK-15 line) would be exposed repeatedly to swine agents during routine trypsinization for passage. The presence of virus in swine pancreas-derived trypsin would not be surprising because swine mycoplasma are common contaminants of cell cultures which are exposed to swine-derived trypsin (3) . Now that we have developed a method for detecting SPV, we are examining trypsin and swine cells from many sources for the presence of this agent.
